Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR52B2 Inhibitors

OR52B2 is a member of the olfactory receptor family of genes, which play a critical role in the detection of odorants and the initiation of olfactory signal transduction. Like other olfactory receptors, OR52B2 is expressed in the sensory neurons of the nasal epithelium and is responsible for the perception of specific volatile compounds. The expression of this receptor is tightly regulated at the transcriptional level, where a complex interplay of transcription factors, epigenetic modifications, and chromatin remodeling events converge to ensure precise control. Disruptions in the expression of OR52B2 can alter olfactory function, highlighting the importance of maintaining its proper regulation. Scientists have identified a range of chemical compounds that could potentially serve as inhibitors of OR52B2 expression through various biochemical pathways. For instance, Trichostatin A and Vorinostat are known histone deacetylase inhibitors; they could reduce OR52B2 expression by promoting a closed chromatin conformation that is not conducive to gene transcription. Similarly, 5-Azacytidine, by inhibiting DNA methyltransferase, might lead to the demethylation of the OR52B2 gene promoter, potentially hindering the binding of transcriptional repressors and resulting in suppressed gene activity. Compounds like Disulfiram could alkylate DNA bases, possibly blocking transcription factor access to the OR52B2 promoter and thus reducing gene expression levels. Meanwhile, Genistein may target the epigenetic regulation of OR52B2 by inducing demethylation of cytosine residues in the gene's promoter region, disrupting essential DNA-protein interactions necessary for transcription initiation. These inhibitors operate by altering the epigenetic landscape or interfering with the transcriptional machinery necessary for OR52B2 gene expression, offering insight into the complex regulation of olfactory receptors.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may lead to the downregulation of OR52B2 by promoting acetylation of histones, thereby changing the chromatin structure to a state that suppresses the initiation of transcription at the OR52B2 gene locus.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase activity, 5-Azacytidine could decrease methylation levels of the OR52B2 gene promoter, potentially reducing the binding of transcriptional repressors and leading to decreased OR52B2 expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A may bind to specific DNA sequences upstream of OR52B2, obstructing the binding sites for transcriptional activators, leading to a reduction in OR52B2 transcription.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid could decrease OR52B2 expression through retinoic acid receptor-mediated repression of transcription factor activity that is essential for the initiation of OR52B2 transcription.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin has the potential to downregulate OR52B2 expression by altering the histone code at the OR52B2 promoter region, specifically by increasing the levels of histone marks associated with a closed chromatin state.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate might inhibit OR52B2 expression by hyperacetylating histones at the OR52B2 gene promoter, which can lead to the recruitment of transcriptional co-repressors that silence gene expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol could decrease OR52B2 expression by altering the transcriptional machinery assembly at the OR52B2 promoter, specifically by changing the conformation of DNA to a state less conducive to transcription initiation.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram could lead to the inhibition of OR52B2 expression through the alkylation of DNA bases within the OR52B2 promoter region, which might obstruct the binding of essential transcriptional machinery.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea might downregulate OR52B2 by depleting the pool of deoxyribonucleotide triphosphates, leading to a general attenuation of DNA synthesis required for gene transcription, including that of OR52B2.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein could lead to the downregulation of OR52B2 by inducing demethylation of cytosine residues within the promoter region of the gene, thereby disrupting the recruitment of DNA-binding proteins necessary for gene activation.